Position in AMLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,155,439
+$517,180 QoQ
Shares Held
227,010
+3.9% QoQ
Ownership
0.204%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SummitTX Capital, L.P. holds $14,798,000 across 7 Drug Manufacturers - Specialty & Generic names. AMLX ranks #3 (21.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
156,259 | $5,525,318 | |
| 2 | PAHC |
Phibro Animal Health Corp
|
75,466 | $4,174,024 | |
| 3 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
227,010 | $3,155,439 | |
| 4 | PRGO |
PERRIGO Co plc
|
70,375 | $755,827 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
9,045 | $467,536 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
41,165 | $391,890 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
15,798 | $327,966 |
All Filings in AMLX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,155,439 | 227,010 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,638,259 | 218,399 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,283,120 | 168,000 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||